Gary A. Piazza
78Patents
17h-index
22Co-inventors
84Inventor score
Filing activity: May 31, 1991 → Nov 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6046206A | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives | Human Necessities | 67 | Expired |
| US6348032B1 | Method of inhibiting neoplastic cells with benzimidazole derivatives | Chemistry; Metallurgy | 60 | Expired |
| US6133271A | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives | Human Necessities | 52 | Expired |
| US6358992B1 | Method of inhibiting neoplastic cells with indole derivatives | Human Necessities | 51 | Expired |
| US6211177A | Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives | Human Necessities | 45 | Expired |
| US5948911A | Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives | Chemistry; Metallurgy | 43 | Expired |
| US5565439A | Methods of using lysophosphatidic acid for treating hyperproliferative conditions | Human Necessities | 35 | Expired |
| US5858694A | Method for identifying compounds for inhibition of cancerous lesions | Physics | 34 | Expired |
| US5990117A | Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives | Human Necessities | 30 | Expired |
| US6200980A | Method of treating a patient having precancerous lesions with phenyl purinone derivatives | Chemistry; Metallurgy | 26 | Expired |
| US5852035A | Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines | Human Necessities | 22 | Expired |
| US6380206B1 | Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives | Human Necessities | 22 | Expired |
| US5965619A | Method for treating patients having precancerous lesions with substituted indene derivatives | Human Necessities | 22 | Expired |
| US5874440A | Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives | Human Necessities | 20 | Expired |
| US6410584B1 | Method for inhibiting neoplastic cells with indole derivatives | Human Necessities | 20 | Expired |
| US6262059A | Method of treating a patient having precancerous lesions with quinazoline derivatives | Human Necessities | 18 | Expired |
| US5238965A | Methods of using lysophosphatidic acids for regulating skin wrinkles | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6121321A | Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions | Human Necessities | 15 | Expired |
| US6063818A | Substituted benzylidene indenyl formamides, acetamides and propionamides | Human Necessities | 15 | Expired |
| US6071934A | Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions | Human Necessities | 15 | Expired |
| US6232312A | Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides | Human Necessities | 15 | Expired |
| US5942520A | Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines | Human Necessities | 15 | Expired |
| US5340568A | Topical composition and method containing deoxy and halo derivatives of lysophosphatidic acids for regulating skin wrinkles | Human Necessities | 15 | Expired |
| US8044048B2 | Derivatives of sulindac, use thereof and preparation thereof | Chemistry; Metallurgy | 14 | Active |
| US5521223A | Methods of using lysophosphatidic acids for regulating skin wrinkles | Emerging Cross-Sectional Technologies | 12 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.